We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Disclosures
- Unifying mechanisms
- Neuroimmune crosstalk
- Microglia and macrophages
- Peripheral vs. CNS immune responses
- How and when?
- Human longevity, genetics and inflammation
- The janus head of immune aging
- Inflammation to neurodegeneration
- Acute inflammation
- Chronic inflammation
- How inflammation links to dementia
- Innate immune dysfunction
- Involvement of gut microbiota
- Signaling inflammation across the GBA
- GBA in inflammation-associated diseases
- Motor and non-motor PD symptoms
- The perfect storm for PD development
- Non-motor PD symptoms
- Body first vs. brain first
- Environmental toxicants
- Gut barrier is critical for brain health
- Intestinal inflammation
- What do we know?
- Gut dysbiosis
- Inflammation, loss of SCFAs and leaky gut
- Short-Chain Fatty Acids (SCFAs)
- Association between IBD and PD risk
- Inflammatory bowel disease (IBD)
- PD and IBD gut microbiome comparison
- Demographics of publicly available datasets
- ANCOM-BC2 differential abundance analyses
- Shared depletion: Bacteria
- Shared depletions: SCFA-synthesis pathways
- Comparison to UFPF dataset
- Similarities in taxonomic depletions
- Conclusions
- Take home message
Topics Covered
- Inflammation and neurodegeneration
- Gut microbiota
- Gut-brain-axis
- Symptoms of PD
- Body first vs. brain first
- Gut barrier and dysbiosis
- Loss of SCFAs
- IBD and PD risk
Links
Series:
Categories:
Therapeutic Areas:
External Links
Talk Citation
Gámez Tansey, M. (2025, January 30). Role of inflammation in the pathogenesis of Parkinson’s disease [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved February 5, 2025, from https://doi.org/10.69645/BEAA4322.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Malú Gámez Tansey has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Immunology & Inflammation
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. My name is
Malú Gámez Tansey.
I am a professor of
Neuroscience and Neurology at
the University of Florida,
College of Medicine.
Today I'm going to talk
to you about the role of
inflammation in the pathogenesis
of Parkinson's disease.
0:19
Here are my disclosures.
0:22
I'd like to begin by
reminding you that there are
unifying mechanisms
of neurodegeneration
that are shared across
neurodegenerative diseases.
There are five or six main
areas of mechanistic overlap.
These include aging,
environmental factors
such as age, diet,
exercise and lifestyle,
head injuries, pesticide,
solvent exposure.
Metabolic and oxidative stress
is another main category.
Genetic contributors, the
neovascular coupling or
blood brain barrier breakdown.
Finally, neuroinflammation and
the central-peripheral
neuroimmune crosstalk
with organs outside the brain.
We are particularly
interested in this last one,
neuroinflammation and
central peripheral
neuroimmune crosstalk and
its complex interactions
with the other
unifying mechanisms.
1:22
We are particularly interested
in the neuroimmune
crosstalk between
central and peripheral
compartments
which is very critical
for brain health.
The reason for this is because
the brain is not
immune privileged.
If anything, it's
immune specialized.
What this means is that
substances cross from
the periphery across
the blood brain barrier
into the central nervous system,
and substances are able to
cross even when
there's alterations.
But the traffic of
these substances
and the cells becomes
disregulated.